Additionally, the most recent efforts directed toward the CDKN1A gene have demonstrated that downregulation of this gene leads to colon cancer progression [67], and similar results have been reported for MAPK10 [68]. This evidence concerns the gene CDKN1A and malignant colon neoplasm.